Obecabtagene autoleucel (obe-cel) for Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Deep Molecular Remission May Predict Better OutcomesElias Jabbour, Claire Roddie, Karamjeet Sandhu et al.|Blood|2024Cited by 3
Deep Molecular Remission Predicts Better Clinical Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) Treated with Obecabtagene Autoleucel (obe-cel)Elias Jabbour, Claire Roddie, Jae H. Park et al.|Transplantation and Cellular Therapy|2025Cited by 2